Inhibition of cellular Cdk2 activity blocks human cytomegalovirus replication

Virology

Volumn 231, Issue 2, 1997, Pages 239-247

  Bresnahan, Wade A ^a   Boldogh, Istvan ^a   Chi, Ping ^a   Thompson, E Aubrey ^a   Albrecht, Thomas ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE;

ARTICLE; CELL CYCLE; CYTOMEGALOVIRUS; DNA SYNTHESIS; DOSE RESPONSE; ENZYME ACTIVATION; NONHUMAN; PRIORITY JOURNAL; VIRUS PATHOGENESIS; VIRUS REPLICATION;

EID: 0031009357     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8489     Document Type: Article

References (39)

1. Albrecht T., Weller T. H. Heterogeneous morphologic features of plaques induced by five strains of human cytomegalovirus. Am. J. Clin. Pathol. 73:1980;648-654.
2. Albrecht T., Boldogh I., Fons M., Lee C. H., AbuBakar S., Russell J. M., Au W. W. Cell-activation responses to cytomegalovirus infection: Relationship to the phasing of CMV replication and to the induction of cellular damage. Subcell. Biochem. 15:1989;157-202.
3. Alford C. A., Stagno S., Pass R. F., Britt W. Congenital and perinatal cytomegalovirus infections. Rev. Infect. Dis. 12:1990;S745-S753.
4. Boldogh I., AbuBakar S., Albrecht T. Activation of proto-oncogenes: An immediate early event in human cytomegalovirus infection. Science. 247:1990;961-964.
5. Boldogh I., AbuBakar S., Millinoff D., Deng C. Z., Albrecht T. Cellular oncogene activation by human cytomegalovirus: Lack of correlation with virus infectivity and immediate early gene expression. Arch Virol. 118:1991;163-177.
6. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
7. Bresnahan W. A., Boldogh I., Thompson E. A., Albrecht T. Human cytomegalovirus inhibits cellular DNA synthesis and arrests productively infected cells in late G1. Virology. 224:1996;150-160.
8. Cao L., Faha M., Dembski L., Tsai H., Harlow E. Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F. Nature (London). 355:1992;176-179.
9. Cardoso M. C., Leonhardt H., Nadal-Ginard B. Reversal of terminal differentiation and control of DNA replication: Cyclin A and Cdk2 specifically localize at subnuclear sites of DNA replication. Cell. 74:1993;979-992.
10. Dal Monte P., Bessia C., Ripalti A., Landini M. P., Topilko A., Plachter B., Virelizier J. L., Michelson S. Stably expressed antisense RNA to cytomegalovirus UL83 inhibits viral replication. J. Virol. 70:1996;2086-2094.
11. DeMarchi J. M. Correlation between stimulation of host cell DNA synthesis by human cytomegalovirus and lack of expression of a subset of early virus genes. Virology. 129:1983;274-286.
12. Dittmer D., Mocarski E. S. Human cytomegalovirus infection inhibits G1/S transition. J. Virol. 71:1997;1629-1634.
13. Dulic V., Lees E., Reed S. I. Association of human cyclin E with a periodic G1-S phase protein kinase. Science. 257:1992;1958-1961.
14. Estes J. E., Huang E.-S. Stimulation of cellular thymidine kinases by human cytomegalovirus. J. Virol. 24:1977;13-21.
15. Farnham P. J., Slansky J. E., Kollmar R. The role of E2F in the mammalian cell cycle. Biochim. Biophys. Acta. 1155:1993;125-131.
16. Girard F., Strausfeld U., Fernandez A., Lamb N. Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell. 67:1991;1169-1179.
17. Honess R. W., Roizman B. Regulation of herpesvirus macromolecular synthesis: Sequential transition of polypeptide synthesis requires viral polypeptides. Proc. Natl. Acad. Sci. USA. 72:1975;1276-1280.
18. Huang E.-S. Human cytomegalovirus IV. Specific inhibition of virus-induced DNA polymerase activity and viral DNA replication by phosphonoacetic acid. J. Virol. 16:1975;1560-1565.
19. Cip1. J. Cell Biol. 130:1995;755-769.
20. Jault F., Jault J., Ruchti F., Fortunato E., Clark C., Corbeil J., Richman D., Spector D. H. Cytomegalovirus infection induced high levels of cyclins, phosphorylated Rb, and p53, leading to cell cycle arrest. J. Virol. 69:1995;6697-6704.
21. Lu M., Shenk T. Human cytomegalovirus infection inhibits cell cycle progression at multiple points, including the transition from G1 to S. J. Virol. 70:1996;8850-8857.
22. Malone C. L., Vesole D. H., Stinski M. F. Transactivation of a human cytomegalovirus early promoter by gene products from the immediate-early gene IE2 and augmentation by IE1: Mutational analysis of the viral proteins. J. Virol. 64:1990;1498-1506.
23. Margolis M. J., Pajovic S., Wong E. L., Wade M., Jupp R., Nelson J. A., Azizkhan J. C. Interaction of the 72-kilodalton human cytomegalovirus IE1 gene product with E2F1 coincides with E2F-dependent activation of dihydrofolate reductase transcription. J. Virol. 69:1995;7759-7767.
24. Meijer L. Chemical inhibitors of cyclin-dependent kinases. Trends Cell Biol. 6:1996;393-397.
25. Monick M. M., Geist L. J., Stinski M. F., Hunninghake G. W. The immediate early genes of human cytomegalovirus upregulate expression of the cellular genesmycfos. Am. J. Respir. Cell Mol. Biol. 7:1992;251-256.
26. Morin J., Johann S., O'Hara B., Gluzman Y. Exogenous thymidine is preferentially incorporated into human cytomegalovirus DNA in infected human fibroblasts. J. Virol. 70:1996;6402-6404.
27. Nevins J. R. E2F: a link between the Rb tumor suppressor and viral oncoproteins. Science. 258:1992;424-429.
28. Poma E., Kowalik T. F., Zhu L., Sinclair J. H., Huang E-S. The human cytomegalovirus IE1-72 protein interacts with the cellular p107 protein and relieves p107-mediated transcriptional repression of an E2F-responsive promoter. J. Virol. 70:1996;7867-7877.
29. Kip1. Mol. Cell. Biol. 15:1995;4347-4352.
30. Ripalti A., Boccuni M. C., Campanini F., Landini M. P. Cytomegalovirus-mediated induction of antisense mRNA expression to UL44 inhibits virus replication in an astrocytoma cell line: Identification of an essential gene. J. Virol. 69:1995;2047-2057.
31. Rubin R. Impact of cytomegalovirus infection on organ transplant recipients. Rev. Infect. Dis. 12:1990;S754-S766.
32. Rudolph B., Saffrich R., Zwicker J., Henglein B., Muller R., Ansorge W., Eilers M. Activation of cyclin-dependent kinases by Myc mediates induction of cyclin A, but not apoptosis. EMBO J. 15:1996;3065-3075.
33. Schooley R. T. Cytomegalovirus in the setting of infection with human immunodeficiency virus. Rev. Infect. Dis. 12:1990;S811-S819.
34. van den Heuvel S., Harlow E. Distinct roles for cyclin-dependent kinases in cell cycle control. Science. 262:1993;2050-2054.
35. Vesely J., Havlicek L., Strnad M., Blow J. J., Donella-Deana A., Pinna D. S., Letham D. S., Kato J., Detivaud L., Leclerc S., Meijer L. Inhibition of cyclin-dependent kinases by purine analogues. Eur. J. Biochem. 224:1994;771-786.
36. Wade M., Kowalik T. F., Mudryj M., Huang E.-S., Azizkhan J. C. E2F mediates dihydrofolate reductase promoter activation and multiprotein complex formation in human cytomegalovirus infection. Mol. Cell. Biol. 12:1992;4364-4374.
37. Wathen M. W., Stinski M. F. Temporal patterns of human cytomegalovirus transcription: Mapping the viral RNAs synthesized at immediate early, early, and late times after infection. J. Virol. 41:1982;462-477.
38. Weinberg R. The retinoblastoma and cell cycle control. Cell. 81:1995;323-330.
39. Welch A. R., McNally L. M., Gibson W. Cytomegalovirus assembly protein nested gene family: Four 3′-coterminal transcripts encode four in-frame, overlapping proteins. J. Virol. 65:1991;4091-4100.